查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1762359

直接口服抗凝固药(DOAC)设备市场，规模，占有率，趋势，产业分析报告:各产品类型，各疾病适应症，各用途，患者层，各终端用户，各地区，2025年～2034年的市场预测

Direct Oral Anticoagulants (DOACs) Device Market Size, Share, Trends, & Industry Analysis Report By Product Type, By Disease Indication, By Application, By Patient Demographic, By End User, and By Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 130 Pages | 商品交期: 最快1-2个工作天内

价格

根据 Polaris Market Research 的最新研究，预计到 2034 年，直接口服抗凝血剂 (DOAC) 器械市场规模将达到 648.3 亿美元。本研究报告深入分析了当前的市场动态，并分析了未来的市场成长。

直接口服抗凝血剂 (DOAC) 器械是一种专用诊断工具，旨在监测使用直接口服抗凝血剂的患者的抗凝血水平，以确保安全有效的治疗结果。这些器械透过提供准确、即时的凝血状态洞察，在临床决策中发挥关键作用，尤其是在中风预防、静脉血栓栓塞症管理和术后护理方面。

凝血检测对于提高治疗准确性、最大限度地减少不良事件以及支持医院、门诊中心和家庭护理机构的个人化患者护理至关重要。检测灵敏度、设备便携性和数位连接性的进步正在提高诊断效率，并扩大这些系统在急性和慢性护理途径中的实用性。将其整合到常规临床工作流程中有助于改善患者预后、简化监测并优化整体医疗保健成本。

直接口服抗凝血剂 (DOAC) 设备市场报告要点

按应用划分，中风预防领域在 2024 年引领市场，这主要是由于心房颤动和其他需要抗凝血治疗的心血管疾病的盛行率不断上升。

按最终用户划分，医院在预测期内预计的复合年增长率最高，因为它们是综合管理急性血栓事件和慢性抗凝血治疗的主要医疗机构。

预计到2024年，北美将在DOAC设备市场占据最大的收入占有率，这得益于其先进的医疗基础设施、较高的血栓栓塞性疾病负担以及医疗机构广泛采用直接口服抗凝血剂。

预计亚太市场将实现稳定成长，这得益于医疗成本的上涨、人们对凝血障碍认识的不断提高以及预防性和个人化医疗的日益普及。

目录

第1章 简介

第2章 摘要整理

第3章 调查手法

第4章 全球直接口服抗凝固药(DOAC)设备市场洞察

  • 市场概述
  • 直接口服抗凝固药(DOAC)设备市场动态
    • 促进因素和机会
      • 全球血栓栓塞负担日益加重
      • 全球人口老化，心血管疾病风险上升
    • 阻碍因素与课题
      • 先进诊断设备成本高昂
  • PESTEL分析
  • 直接口服抗凝固药(DOAC)设备市场趋势
  • 价值链分析

第5章 全球直接口服抗凝固药(DOAC)设备市场:各产品类型

  • 主要调查结果
  • 简介
  • Xa 因子抑制剂
  • 直接凝血[酉每]抑制剂

第6章 全球直接口服抗凝固药(DOAC)设备市场:各疾病适应症

  • 主要调查结果
  • 简介
  • 心房颤动
  • 深部静脉血栓症(DVT)
  • 肺动脉栓塞(PE)
  • 心臟病发作
  • 术后血栓预防
  • 其他

第7章 全球直接口服抗凝固药(DOAC)设备市场:各用途

  • 主要调查结果
  • 简介
  • 中风预防
  • 静脉血栓栓塞症的预防
  • 急性血栓症的治疗
  • 长期预防
  • 其他的用途

第8章 全球直接按口服抗凝固药(DOAC)设备市场:患者层

  • 主要调查结果
  • 简介
  • 儿童
  • 成人
  • 老年人

第9章 全球直接口服抗凝固药(DOAC)设备市场:各终端用户

  • 主要调查结果
  • 简介
  • 医院
  • 门诊病人手术中心
  • 专门诊所
  • 居家照护环境
  • 其他

第10章 全球直接口服抗凝固药(DOAC)设备市场:各地区

  • 主要调查结果
  • 简介
    • 直接口服抗凝固药(DOAC)设备市场评估:各地区，2020年～2034年
  • 北美
    • 北美:各产品类型，2020～2034年
    • 北美:各疾病，2020～2034年
    • 北美:各用途，2020～2034年
    • 北美:患者层，2020～2034年
    • 北美:各终端用户，2020～2034年
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲:各产品类型，2020～2034年
    • 欧洲:各疾病，2020～2034年
    • 欧洲:各用途，2020～2034年
    • 欧洲:患者层，2020～2034年
    • 欧洲:各终端用户，2020～2034年
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
    • 其他欧洲
  • 亚太地区
    • 亚太地区:各产品类型，2020～2034年
    • 亚太地区:各疾病，2020年～2034年
    • 亚太地区:各用途，2020～2034年
    • 亚太地区:患者层，2020～2034年
    • 亚太地区:各终端用户，2020～2034年
    • 中国
    • 印度
    • 马来西亚
    • 日本
    • 印尼
    • 韩国
    • 澳洲
    • 其他亚太地区
  • 中东·非洲
    • 中东·非洲:各产品类型，2020～2034年
    • 中东·非洲:各疾病，2020年～2034年
    • 中东·非洲:各用途，2020～2034年
    • 中东·非洲:患者层，2020～2034年
    • 中东·非洲:各终端用户，2020～2034年
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 以色列
    • 南非
    • 其他中东和非洲
  • 南美
    • 南美:各产品类型，2020-2034年
    • 南美:各疾病，2020年～2034年
    • 南美:各用途，2020～2034年
    • 南美:患者层，2020～2034年
    • 南美:各终端用户，2020～2034年
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他南美国家

第11章 竞争情形

  • 扩大和收购的分析
    • 扩大
    • 收购
  • 联盟/合作/协定/公开

第12章 企业简介

  • Siemens Healthineers
  • Abbott Laboratories
  • Roche Diagnostics
  • Sysmex Corporation
  • Instrumentation Laboratory(Werfen)
  • Nihon Kohden Corporation
  • Diagnostica Stago
  • Coag-Sense
  • HemoSonics
  • Sekisui Medical Co., Ltd.
  • Grifols S.A.
  • Helena Laboratories Corporation
Product Code: PM5800

The direct oral anticoagulants device market size is expected to reach USD 64.83 Billion by 2034, according to a new study by Polaris Market Research. The report "Direct Oral Anticoagulants (DOACs) Device Market Share, Size, Trends, Industry Analysis Report: By Product Type, By Disease Indication, By Application, By Patient Demographic, By End User, and By Region; Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Direct Oral Anticoagulants (DOACs) Device coagulation devices are specialized diagnostic tools designed to monitor anticoagulation levels in patients using direct oral anticoagulants, ensuring safe and effective therapeutic outcomes. These devices play a critical role in clinical decision-making by providing accurate, real-time insights into coagulation status, particularly in stroke prevention, venous thromboembolism management, and post-surgical care.

They are essential for improving treatment precision, minimizing adverse events, and supporting individualized patient care across hospitals, ambulatory centers, and homecare settings. Advancements in assay sensitivity, device portability, and digital connectivity are enhancing diagnostic efficiency and expanding the utility of these systems in both acute and chronic care pathways. Their integration into routine clinical workflows contributes to better patient outcomes, streamlined monitoring, and overall healthcare cost optimization.

Direct Oral Anticoagulants (DOACs) Device Market Report Highlights

In terms of application, the stroke prevention segment led the market in 2024, primarily due to rising prevalence of atrial fibrillation and other cardiovascular conditions requiring anticoagulation therapy.

In terms of end user, the hospitals are expected to register the highest CAGR during the forecast period, as they serve as the primary healthcare setting for comprehensive management of both acute thrombotic events and chronic anticoagulation requirements.

North America captured the largest revenue share in the DOAC device market in 2024, owing to its sophisticated healthcare infrastructure, high thromboembolic disease burden, and widespread clinical adoption of direct oral anticoagulants across care settings.

The Asia Pacific market is anticipated to demonstrate consistent growth, fueled by increasing healthcare expenditure, greater awareness of coagulation disorders, and a progressive transition toward preventive care and personalized treatment approaches.

A few global key market players include Siemens Healthineers, Abbott Laboratories, Roche Diagnostics, Sysmex Corporation, Instrumentation Laboratory (Werfen), Nihon Kohden Corporation, Diagnostica Stago, Coag-Sense, HemoSonics, Sekisui Medical Co., Ltd., Grifols S.A., and Helena Laboratories Corporation.

Polaris Market Research has segmented the market report on the basis of product type, disease indication, application, patient demographic, end user, and region:

By Product Type Outlook (Revenue, USD Billion, 2020-2034)

Factor Xa Inhibitors

Direct Thrombin Inhibitors

By Disease Indication Outlook (Revenue, USD Billion, 2020-2034)

Atrial Fibrillation

Deep Vein Thrombosis (DVT)

Pulmonary Embolism (PE)

Heart Attacks

Post-Surgical Thromboprophylaxis

Others

By Application Outlook (Revenue, USD Billion, 2020-2034)

Stroke Prevention

Venous Thromboembolism Prevention

Treatment of Acute Thrombotic Events

Long-Term Prophylaxis

Other Application

By Patient Demographic Outlook (Revenue, USD Billion, 2020-2034)

Paediatric

Adult

Geriatric

By End User Outlook (Revenue, USD Billion, 2020-2034)

Hospitals

Ambulatory Surgical Centers

Specialty Clinics

Homecare Settings

Others

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Direct Oral Anticoagulants (DOACs) Device Market Insights

  • 4.1. Direct Oral Anticoagulants (DOACs) Device Market - Market Snapshot
  • 4.2. Direct Oral Anticoagulants (DOACs) Device Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing Global Burden of Thromboembolic Disorders
      • 4.2.1.2. Aging Global Population with High Cardiovascular Risk
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Cost of Advanced Diagnostic Devices
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Direct Oral Anticoagulants (DOACs) Device Market Trends
  • 4.6. Value Chain Analysis

5. Global Direct Oral Anticoagulants (DOACs) Device Market, by Product Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
  • 5.3. Factor Xa Inhibitors
    • 5.3.1. Global Direct Oral Anticoagulants (DOACs) Device Market, by Factor Xa Inhibitors, by Region, 2020-2034 (USD Billion)
  • 5.4. Direct Thrombin Inhibitors
    • 5.4.1. Global Direct Oral Anticoagulants (DOACs) Device Market, by Direct Thrombin Inhibitors, by Region, 2020-2034 (USD Billion)

6. Global Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
  • 6.3. Atrial Fibrillation
    • 6.3.1. Global Direct Oral Anticoagulants (DOACs) Device Market, by Atrial Fibrillation, by Region, 2020-2034 (USD Billion)
  • 6.4. Deep Vein Thrombosis (DVT)
    • 6.4.1. Global Direct Oral Anticoagulants (DOACs) Device Market, by Deep Vein Thrombosis (DVT), by Region, 2020-2034 (USD Billion)
  • 6.5. Pulmonary Embolism (PE)
    • 6.5.1. Global Direct Oral Anticoagulants (DOACs) Device Market, by Pulmonary Embolism (PE), by Region, 2020-2034 (USD Billion)
  • 6.6. Heart Attacks
    • 6.6.1. Global Direct Oral Anticoagulants (DOACs) Device Market, by Heart Attacks, by Region, 2020-2034 (USD Billion)
  • 6.7. Post-Surgical Thromboprophylaxis
    • 6.7.1. Global Direct Oral Anticoagulants (DOACs) Device Market, by Post-Surgical Thromboprophylaxis, by Region, 2020-2034 (USD Billion)
  • 6.8. Others
    • 6.8.1. Global Direct Oral Anticoagulants (DOACs) Device Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Direct Oral Anticoagulants (DOACs) Device Market, by Application

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
  • 7.3. Stroke Prevention
    • 7.3.1. Global Direct Oral Anticoagulants (DOACs) Device Market, by Stroke Prevention, by Region, 2020-2034 (USD Billion)
  • 7.4. Venous Thromboembolism Prevention
    • 7.4.1. Global Direct Oral Anticoagulants (DOACs) Device Market, by Venous Thromboembolism Prevention, by Region, 2020-2034 (USD Billion)
  • 7.5. Treatment of Acute Thrombotic Events
    • 7.5.1. Global Direct Oral Anticoagulants (DOACs) Device Market, by Treatment of Acute Thrombotic Events, by Region, 2020-2034 (USD Billion)
  • 7.6. Long-Term Prophylaxis
    • 7.6.1. Global Direct Oral Anticoagulants (DOACs) Device Market, by Long-Term Prophylaxis, by Region, 2020-2034 (USD Billion)
  • 7.7. Other Application
    • 7.7.1. Global Direct Oral Anticoagulants (DOACs) Device Market, by Other Application, by Region, 2020-2034 (USD Billion)

8. Global Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
  • 8.3. Paediatric
    • 8.3.1. Global Direct Oral Anticoagulants (DOACs) Device Market, by Paediatric, by Region, 2020-2034 (USD Billion)
  • 8.4. Adult
    • 8.4.1. Global Direct Oral Anticoagulants (DOACs) Device Market, by Adult, by Region, 2020-2034 (USD Billion)
  • 8.5. Geriatric
    • 8.5.1. Global Direct Oral Anticoagulants (DOACs) Device Market, by Geriatric, by Region, 2020-2034 (USD Billion)

9. Global Direct Oral Anticoagulants (DOACs) Device Market, by End User

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Global Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
  • 9.3. Hospitals
    • 9.3.1. Global Direct Oral Anticoagulants (DOACs) Device Market, by Hospitals, by Region, 2020-2034 (USD Billion)
  • 9.4. Ambulatory Surgical Centers
    • 9.4.1. Global Direct Oral Anticoagulants (DOACs) Device Market, by Ambulatory Surgical Centers, by Region, 2020-2034 (USD Billion)
  • 9.5. Specialty Clinics
    • 9.5.1. Global Direct Oral Anticoagulants (DOACs) Device Market, by Specialty Clinics, by Region, 2020-2034 (USD Billion)
  • 9.6. Homecare Settings
    • 9.6.1. Global Direct Oral Anticoagulants (DOACs) Device Market, by Homecare Settings, by Region, 2020-2034 (USD Billion)
  • 9.7. Others
    • 9.7.1. Global Direct Oral Anticoagulants (DOACs) Device Market, by Others, by Region, 2020-2034 (USD Billion)

10. Global Direct Oral Anticoagulants (DOACs) Device Market, by Geography

  • 10.1. Key Findings
  • 10.2. Introduction
    • 10.2.1. Direct Oral Anticoagulants (DOACs) Device Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 10.3. Direct Oral Anticoagulants (DOACs) Device Market - North America
    • 10.3.1. North America: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
    • 10.3.2. North America: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
    • 10.3.3. North America: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
    • 10.3.4. North America: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
    • 10.3.5. North America: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
    • 10.3.6. Direct Oral Anticoagulants (DOACs) Device Market - U.S.
      • 10.3.6.1. U.S.: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
      • 10.3.6.2. U.S.: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
      • 10.3.6.3. U.S.: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
      • 10.3.6.4. U.S.: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
      • 10.3.6.5. U.S.: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
    • 10.3.7. Direct Oral Anticoagulants (DOACs) Device Market - Canada
      • 10.3.7.1. Canada: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
      • 10.3.7.2. Canada: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
      • 10.3.7.3. Canada: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
      • 10.3.7.4. Canada: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
      • 10.3.7.5. Canada: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
  • 10.4. Direct Oral Anticoagulants (DOACs) Device Market - Europe
    • 10.4.1. Europe: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
    • 10.4.2. Europe: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
    • 10.4.3. Europe: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
    • 10.4.4. Europe: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
    • 10.4.5. Europe: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
    • 10.4.6. Direct Oral Anticoagulants (DOACs) Device Market - UK
      • 10.4.6.1. UK: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
      • 10.4.6.2. UK: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
      • 10.4.6.3. UK: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
      • 10.4.6.4. UK: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
      • 10.4.6.5. UK: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
    • 10.4.7. Direct Oral Anticoagulants (DOACs) Device Market - France
      • 10.4.7.1. France: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
      • 10.4.7.2. France: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
      • 10.4.7.3. France: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
      • 10.4.7.4. France: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
      • 10.4.7.5. France: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
    • 10.4.8. Direct Oral Anticoagulants (DOACs) Device Market - Germany
      • 10.4.8.1. Germany: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
      • 10.4.8.2. Germany: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
      • 10.4.8.3. Germany: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
      • 10.4.8.4. Germany: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
      • 10.4.8.5. Germany: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
    • 10.4.9. Direct Oral Anticoagulants (DOACs) Device Market - Italy
      • 10.4.9.1. Italy: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
      • 10.4.9.2. Italy: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
      • 10.4.9.3. Italy: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
      • 10.4.9.4. Italy: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
      • 10.4.9.5. Italy: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
    • 10.4.10. Direct Oral Anticoagulants (DOACs) Device Market - Spain
      • 10.4.10.1. Spain: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
      • 10.4.10.2. Spain: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
      • 10.4.10.3. Spain: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
      • 10.4.10.4. Spain: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
      • 10.4.10.5. Spain: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
    • 10.4.11. Direct Oral Anticoagulants (DOACs) Device Market - Netherlands
      • 10.4.11.1. Netherlands: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
      • 10.4.11.2. Netherlands: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
      • 10.4.11.3. Netherlands: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
      • 10.4.11.4. Netherlands: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
      • 10.4.11.5. Netherlands: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
    • 10.4.12. Direct Oral Anticoagulants (DOACs) Device Market - Russia
      • 10.4.12.1. Russia: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
      • 10.4.12.2. Russia: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
      • 10.4.12.3. Russia: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
      • 10.4.12.4. Russia: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
      • 10.4.12.5. Russia: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
    • 10.4.13. Direct Oral Anticoagulants (DOACs) Device Market - Rest of Europe
      • 10.4.13.1. Rest of Europe: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
      • 10.4.13.2. Rest of Europe: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
      • 10.4.13.3. Rest of Europe: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
      • 10.4.13.4. Rest of Europe: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
      • 10.4.13.5. Rest of Europe: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
  • 10.5. Direct Oral Anticoagulants (DOACs) Device Market - Asia Pacific
    • 10.5.1. Asia Pacific: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
    • 10.5.2. Asia Pacific: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
    • 10.5.3. Asia Pacific: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
    • 10.5.4. Asia Pacific: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
    • 10.5.5. Asia Pacific: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
    • 10.5.6. Direct Oral Anticoagulants (DOACs) Device Market - China
      • 10.5.6.1. China: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
      • 10.5.6.2. China: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
      • 10.5.6.3. China: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
      • 10.5.6.4. China: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
      • 10.5.6.5. China: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
    • 10.5.7. Direct Oral Anticoagulants (DOACs) Device Market - India
      • 10.5.7.1. India: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
      • 10.5.7.2. India: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
      • 10.5.7.3. India: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
      • 10.5.7.4. India: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
      • 10.5.7.5. India: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
    • 10.5.8. Direct Oral Anticoagulants (DOACs) Device Market - Malaysia
      • 10.5.8.1. Malaysia: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
      • 10.5.8.2. Malaysia: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
      • 10.5.8.3. Malaysia: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
      • 10.5.8.4. Malaysia: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
      • 10.5.8.5. Malaysia: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
    • 10.5.9. Direct Oral Anticoagulants (DOACs) Device Market - Japan
      • 10.5.9.1. Japan: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
      • 10.5.9.2. Japan: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
      • 10.5.9.3. Japan: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
      • 10.5.9.4. Japan: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
      • 10.5.9.5. Japan: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
    • 10.5.10. Direct Oral Anticoagulants (DOACs) Device Market - Indonesia
      • 10.5.10.1. Indonesia: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
      • 10.5.10.2. Indonesia: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
      • 10.5.10.3. Indonesia: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
      • 10.5.10.4. Indonesia: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
      • 10.5.10.5. Indonesia: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
    • 10.5.11. Direct Oral Anticoagulants (DOACs) Device Market - South Korea
      • 10.5.11.1. South Korea: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
      • 10.5.11.2. South Korea: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
      • 10.5.11.3. South Korea: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
      • 10.5.11.4. South Korea: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
      • 10.5.11.5. South Korea: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
    • 10.5.12. Direct Oral Anticoagulants (DOACs) Device Market - Australia
      • 10.5.12.1. Australia: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
      • 10.5.12.2. Australia: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
      • 10.5.12.3. Australia: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
      • 10.5.12.4. Australia: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
      • 10.5.12.5. Australia: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
    • 10.5.13. Direct Oral Anticoagulants (DOACs) Device Market - Rest of Asia Pacific
      • 10.5.13.1. Rest of Asia Pacific: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
      • 10.5.13.2. Rest of Asia Pacific: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
      • 10.5.13.3. Rest of Asia Pacific: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
      • 10.5.13.4. Rest of Asia Pacific: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
      • 10.5.13.5. Rest of Asia Pacific: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
  • 10.6. Direct Oral Anticoagulants (DOACs) Device Market - Middle East & Africa
    • 10.6.1. Middle East & Africa: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
    • 10.6.2. Middle East & Africa: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
    • 10.6.3. Middle East & Africa: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
    • 10.6.4. Middle East & Africa: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
    • 10.6.5. Middle East & Africa: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
    • 10.6.6. Direct Oral Anticoagulants (DOACs) Device Market - Saudi Arabia
      • 10.6.6.1. Saudi Arabia: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
      • 10.6.6.2. Saudi Arabia: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
      • 10.6.6.3. Saudi Arabia: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
      • 10.6.6.4. Saudi Arabia: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
      • 10.6.6.5. Saudi Arabia: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
    • 10.6.7. Direct Oral Anticoagulants (DOACs) Device Market - UAE
      • 10.6.7.1. UAE: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
      • 10.6.7.2. UAE: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
      • 10.6.7.3. UAE: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
      • 10.6.7.4. UAE: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
      • 10.6.7.5. UAE: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
    • 10.6.8. Direct Oral Anticoagulants (DOACs) Device Market - Israel
      • 10.6.8.1. Israel: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
      • 10.6.8.2. Israel: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
      • 10.6.8.3. Israel: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
      • 10.6.8.4. Israel: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
      • 10.6.8.5. Israel: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
    • 10.6.9. Direct Oral Anticoagulants (DOACs) Device Market - South Africa
      • 10.6.9.1. South Africa: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
      • 10.6.9.2. South Africa: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
      • 10.6.9.3. South Africa: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
      • 10.6.9.4. South Africa: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
      • 10.6.9.5. South Africa: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
    • 10.6.10. Direct Oral Anticoagulants (DOACs) Device Market - Rest of Middle East & Africa
      • 10.6.10.1. Rest of Middle East & Africa: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
      • 10.6.10.2. Rest of Middle East & Africa: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
      • 10.6.10.3. Rest of Middle East & Africa: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
      • 10.6.10.4. Rest of Middle East & Africa: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
      • 10.6.10.5. Rest of Middle East & Africa: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
  • 10.7. Direct Oral Anticoagulants (DOACs) Device Market - Latin America
    • 10.7.1. Latin America: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
    • 10.7.2. Latin America: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
    • 10.7.3. Latin America: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
    • 10.7.4. Latin America: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
    • 10.7.5. Latin America: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
    • 10.7.6. Direct Oral Anticoagulants (DOACs) Device Market - Mexico
      • 10.7.6.1. Mexico: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
      • 10.7.6.2. Mexico: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
      • 10.7.6.3. Mexico: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
      • 10.7.6.4. Mexico: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
      • 10.7.6.5. Mexico: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
    • 10.7.7. Direct Oral Anticoagulants (DOACs) Device Market - Brazil
      • 10.7.7.1. Brazil: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
      • 10.7.7.2. Brazil: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
      • 10.7.7.3. Brazil: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
      • 10.7.7.4. Brazil: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
      • 10.7.7.5. Brazil: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
    • 10.7.8. Direct Oral Anticoagulants (DOACs) Device Market - Argentina
      • 10.7.8.1. Argentina: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
      • 10.7.8.2. Argentina: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
      • 10.7.8.3. Argentina: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
      • 10.7.8.4. Argentina: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
      • 10.7.8.5. Argentina: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
    • 10.7.9. Direct Oral Anticoagulants (DOACs) Device Market - Rest of Latin America
      • 10.7.9.1. Rest of Latin America: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
      • 10.7.9.2. Rest of Latin America: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
      • 10.7.9.3. Rest of Latin America: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
      • 10.7.9.4. Rest of Latin America: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
      • 10.7.9.5. Rest of Latin America: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)

11. Competitive Landscape

  • 11.1. Expansion and Acquisition Analysis
    • 11.1.1. Expansion
    • 11.1.2. Acquisitions
  • 11.2. Partnerships/Collaborations/Agreements/Exhibitions

12. Company Profiles

  • 12.1. Siemens Healthineers
    • 12.1.1. Company Overview
    • 12.1.2. Financial Performance
    • 12.1.3. Product Benchmarking
    • 12.1.4. Recent Development
  • 12.2. Abbott Laboratories
    • 12.2.1. Company Overview
    • 12.2.2. Financial Performance
    • 12.2.3. Product Benchmarking
    • 12.2.4. Recent Development
  • 12.3. Roche Diagnostics
    • 12.3.1. Company Overview
    • 12.3.2. Financial Performance
    • 12.3.3. Product Benchmarking
    • 12.3.4. Recent Development
  • 12.4. Sysmex Corporation
    • 12.4.1. Company Overview
    • 12.4.2. Financial Performance
    • 12.4.3. Product Benchmarking
    • 12.4.4. Recent Development
  • 12.5. Instrumentation Laboratory (Werfen)
    • 12.5.1. Company Overview
    • 12.5.2. Financial Performance
    • 12.5.3. Product Benchmarking
    • 12.5.4. Recent Development
  • 12.6. Nihon Kohden Corporation
    • 12.6.1. Company Overview
    • 12.6.2. Financial Performance
    • 12.6.3. Product Benchmarking
    • 12.6.4. Recent Development
  • 12.7. Diagnostica Stago
    • 12.7.1. Company Overview
    • 12.7.2. Financial Performance
    • 12.7.3. Product Benchmarking
    • 12.7.4. Recent Development
  • 12.8. Coag-Sense
    • 12.8.1. Company Overview
    • 12.8.2. Financial Performance
    • 12.8.3. Product Benchmarking
    • 12.8.4. Recent Development
  • 12.9. HemoSonics
    • 12.9.1. Company Overview
    • 12.9.2. Financial Performance
    • 12.9.3. Product Benchmarking
    • 12.9.4. Recent Development
  • 12.10. Sekisui Medical Co., Ltd.
    • 12.10.1. Company Overview
    • 12.10.2. Financial Performance
    • 12.10.3. Product Benchmarking
    • 12.10.4. Recent Development
  • 12.11. Grifols S.A.
    • 12.11.1. Company Overview
    • 12.11.2. Financial Performance
    • 12.11.3. Product Benchmarking
    • 12.11.4. Recent Development
  • 12.12. Helena Laboratories Corporation
    • 12.12.1. Company Overview
    • 12.12.2. Financial Performance
    • 12.12.3. Product Benchmarking
    • 12.12.4. Recent Development

List of Tables:

  • Table 1 Global Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
  • Table 2 Global Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 3 Global Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
  • Table 4 Global Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
  • Table 5 Global Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
  • Table 6 North America: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
  • Table 7 North America: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 8 North America: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
  • Table 9 North America: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
  • Table 10 North America: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
  • Table 11 U.S.: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
  • Table 12 U.S.: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 13 U.S.: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
  • Table 14 U.S.: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
  • Table 15 U.S.: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
  • Table 16 Canada: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
  • Table 17 Canada: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 18 Canada: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
  • Table 19 Canada: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
  • Table 20 Canada: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
  • Table 21 Europe: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
  • Table 22 Europe: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 23 Europe: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
  • Table 24 Europe: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
  • Table 25 Europe: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
  • Table 26 UK: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
  • Table 27 UK: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 28 UK: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
  • Table 29 UK: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
  • Table 30 UK: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
  • Table 31 France: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
  • Table 32 France: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 33 France: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
  • Table 34 France: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
  • Table 35 France: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
  • Table 36 Germany: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
  • Table 37 Germany: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 38 Germany: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
  • Table 39 Germany: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
  • Table 40 Germany: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
  • Table 41 Italy: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
  • Table 42 Italy: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 43 Italy: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
  • Table 44 Italy: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
  • Table 45 Italy: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
  • Table 46 Spain: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
  • Table 47 Spain: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 48 Spain: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
  • Table 49 Spain: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
  • Table 50 Spain: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
  • Table 51 Netherlands: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
  • Table 52 Netherlands: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 53 Netherlands: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
  • Table 54 Netherlands: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
  • Table 55 Netherlands: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
  • Table 56 Russia: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
  • Table 57 Russia: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 58 Russia: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
  • Table 59 Russia: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
  • Table 60 Russia: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
  • Table 61 Rest of Europe: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
  • Table 62 Rest of Europe: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 63 Rest of Europe: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
  • Table 64 Rest of Europe: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
  • Table 65 Rest of Europe: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
  • Table 66 Asia Pacific: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
  • Table 67 Asia Pacific: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 68 Asia Pacific: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
  • Table 69 Asia Pacific: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
  • Table 70 Asia Pacific: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
  • Table 71 China: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
  • Table 72 China: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 73 China: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
  • Table 74 China: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
  • Table 75 China: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
  • Table 76 India: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
  • Table 77 India: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 78 India: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
  • Table 79 India: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
  • Table 80 India: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
  • Table 81 Malaysia: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
  • Table 82 Malaysia: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 83 Malaysia: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
  • Table 84 Malaysia: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
  • Table 85 Malaysia: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
  • Table 86 Japan: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
  • Table 87 Japan: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 88 Japan: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
  • Table 89 Japan: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
  • Table 90 Japan: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
  • Table 91 Indonesia: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
  • Table 92 Indonesia: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 93 Indonesia: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
  • Table 94 Indonesia: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
  • Table 95 Indonesia: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
  • Table 96 South Korea: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
  • Table 97 South Korea: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 98 South Korea: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
  • Table 99 South Korea: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
  • Table 100 South Korea: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
  • Table 101 Australia: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
  • Table 102 Australia: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 103 Australia: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
  • Table 104 Australia: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
  • Table 105 Australia: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
  • Table 106 Rest of Asia Pacific: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
  • Table 107 Rest of Asia Pacific: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 108 Rest of Asia Pacific: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
  • Table 109 Rest of Asia Pacific: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
  • Table 110 Rest of Asia Pacific: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
  • Table 111 Middle East & Africa: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
  • Table 112 Middle East & Africa: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 113 Middle East & Africa: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
  • Table 114 Middle East & Africa: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
  • Table 115 Middle East & Africa: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
  • Table 116 Saudi Arabia: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
  • Table 117 Saudi Arabia: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 118 Saudi Arabia: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
  • Table 119 Saudi Arabia: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
  • Table 120 Saudi Arabia: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
  • Table 121 UAE: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
  • Table 122 UAE: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 123 UAE: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
  • Table 124 UAE: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
  • Table 125 UAE: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
  • Table 126 Israel: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
  • Table 127 Israel: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 128 Israel: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
  • Table 129 Israel: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
  • Table 130 Israel: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
  • Table 131 South Africa: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
  • Table 132 South Africa: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 133 South Africa: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
  • Table 134 South Africa: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
  • Table 135 South Africa: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
  • Table 136 Rest of Middle East & Africa: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
  • Table 137 Rest of Middle East & Africa: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 138 Rest of Middle East & Africa: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
  • Table 139 Rest of Middle East & Africa: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
  • Table 140 Rest of Middle East & Africa: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
  • Table 141 Latin America: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
  • Table 142 Latin America: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 143 Latin America: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
  • Table 144 Latin America: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
  • Table 145 Latin America: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
  • Table 146 Mexico: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
  • Table 147 Mexico: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 148 Mexico: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
  • Table 149 Mexico: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
  • Table 150 Mexico: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
  • Table 151 Brazil: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
  • Table 152 Brazil: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 153 Brazil: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
  • Table 154 Brazil: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
  • Table 155 Brazil: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
  • Table 156 Argentina: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
  • Table 157 Argentina: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 158 Argentina: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
  • Table 159 Argentina: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
  • Table 160 Argentina: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
  • Table 161 Rest of Latin America: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
  • Table 162 Rest of Latin America: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 163 Rest of Latin America: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
  • Table 164 Rest of Latin America: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
  • Table 165 Rest of Latin America: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Direct Oral Anticoagulants (DOACs) Device Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Product Type
  • Figure 7. Global Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Disease Indication
  • Figure 9. Global Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2024 & 2034 (USD Billion)
  • Figure 10. Market by Application
  • Figure 11. Global Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2024 & 2034 (USD Billion)
  • Figure 12. Market by Patient Demographic
  • Figure 13. Global Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2024 & 2034 (USD Billion)
  • Figure 14. Market by End User
  • Figure 15. Global Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2024 & 2034 (USD Billion)